131 related articles for article (PubMed ID: 29620186)
1. The transcription factor 7 like 2‑binding protein TIP5 activates β‑catenin/transcription factor signaling in hepatocellular carcinoma.
Li C; Wu W; Ding H; Li Q; Xie K
Mol Med Rep; 2018 Jun; 17(6):7645-7651. PubMed ID: 29620186
[TBL] [Abstract][Full Text] [Related]
2. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T
Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852
[TBL] [Abstract][Full Text] [Related]
3. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.
Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z
Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235
[TBL] [Abstract][Full Text] [Related]
4. PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling.
Liu L; Wu J; Wang S; Luo X; Du Y; Huang D; Gu D; Zhang F
Exp Cell Res; 2017 Sep; 358(2):209-216. PubMed ID: 28648520
[TBL] [Abstract][Full Text] [Related]
5. Aberrant acetylated modification of FGF21‑KLB signaling contributes to hepatocellular carcinoma metastasis through the β‑catenin pathway.
Xia J; Zhu Z; Wen G; Chen Y; An R; Xia S; Guan W; Ren H
Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37350415
[TBL] [Abstract][Full Text] [Related]
6. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
7. Expression and significance of Pin1, β-catenin and cyclin D1 in hepatocellular carcinoma.
Ao R; Zhang DR; Du YQ; Wang Y
Mol Med Rep; 2014 Oct; 10(4):1893-8. PubMed ID: 25109821
[TBL] [Abstract][Full Text] [Related]
8. OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.
Li H; Zhang J; Lee MJ; Yu GR; Han X; Kim DG
Oncotarget; 2017 Mar; 8(11):18129-18144. PubMed ID: 28184024
[TBL] [Abstract][Full Text] [Related]
9. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
12. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor role of sFRP‑4 in hepatocellular carcinoma via the Wnt/β‑catenin signaling pathway.
Wu Q; Xu C; Zeng X; Zhang Z; Yang B; Rao Z
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760186
[TBL] [Abstract][Full Text] [Related]
14. SAC3D1 activates Wnt/β‑catenin signalling in hepatocellular carcinoma.
Wang H; Shi X
Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 36004462
[TBL] [Abstract][Full Text] [Related]
15. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.
Yang YF; Zhang MF; Tian QH; Zhang CZ
J Cell Sci; 2017 Sep; 130(18):3108-3115. PubMed ID: 28754688
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-552 promotes hepatocellular carcinoma progression by downregulating WIF1.
Li C; Wang Z; Chen S; Zhang J; Qu K; Liu C
Int J Mol Med; 2018 Dec; 42(6):3309-3317. PubMed ID: 30221686
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinoma.
Song J; Xie C; Jiang L; Wu G; Zhu J; Zhang S; Tang M; Song L; Li J
Theranostics; 2018; 8(13):3571-3583. PubMed ID: 30026867
[TBL] [Abstract][Full Text] [Related]
18. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
[TBL] [Abstract][Full Text] [Related]
19. PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma.
Yang YF; Pan YH; Cao Y; Fu J; Yang X; Zhang MF; Tian QH
Oncotarget; 2017 Jul; 8(29):47195-47205. PubMed ID: 28525379
[TBL] [Abstract][Full Text] [Related]
20. Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis.
Lu D; Han C; Wu T
Oncogene; 2012 Feb; 31(7):842-57. PubMed ID: 21743491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]